Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

Distribution, prevalence, and genetic analysis of Panulirus argus virus 1 (PaV1) from the Caribbean Sea.

Moss J, Behringer D, Shields JD, Baeza A, Aguilar-Perera A, Bush PG, Dromer C, Herrera-Moreno A, Gittens L, Matthews TR, McCord MR, Schärer MT, Reynal L, Truelove N, Butler MJ.

Dis Aquat Organ. 2013 May 27;104(2):129-40. doi: 10.3354/dao02589.

2.

Neurolipofuscin is a measure of age in Panulirus argus, the Caribbean spiny lobster, in Florida.

Maxwell KE, Matthews TR, Sheehy MR, Bertelsen RD, Derby CD.

Biol Bull. 2007 Aug;213(1):55-66.

PMID:
17679720
3.

Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo.

Freitas VR, Fraser-Smith EB, Matthews TR.

Antiviral Res. 1993 Jan;20(1):1-12.

PMID:
8384431
4.

Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection.

Drew WL, Miner RC, Busch DF, Follansbee SE, Gullett J, Mehalko SG, Gordon SM, Owen WF Jr, Matthews TR, Buhles WC, et al.

J Infect Dis. 1991 Apr;163(4):716-9.

PMID:
1849157
6.
7.

Efficacy of interleukin-1 beta against systemic Candida albicans infections in normal and immunosuppressed mice.

Pecyk RA, Fraser-Smith EB, Matthews TR.

Infect Immun. 1989 Oct;57(10):3257-8. Erratum in: Infect Immun 1990 Apr;58(4):1132.

8.

Susceptibility testing of herpes viruses.

Drew WL, Matthews TR.

Clin Lab Med. 1989 Jun;9(2):279-86. Review.

PMID:
2543536
9.

Kinetics and inhibition of reverse transcriptase from human and simian immunodeficiency viruses.

Wu JC, Chernow M, Boehme RE, Suttmann RT, McRoberts MJ, Prisbe EJ, Matthews TR, Marx PA, Chuang RY, Chen MS.

Antimicrob Agents Chemother. 1988 Dec;32(12):1887-90.

10.

Effect of ketorolac on phagocytosis of Candida albicans by peritoneal macrophages.

Fraser-Smith EB, Matthews TR.

Immunopharmacology. 1988 Nov-Dec;16(3):151-5.

PMID:
3075603
11.

New class of antifungal agents: jasplakinolide, a cyclodepsipeptide from the marine sponge, Jaspis species.

Scott VR, Boehme R, Matthews TR.

Antimicrob Agents Chemother. 1988 Aug;32(8):1154-7.

12.

Effect of ketorolac on Pseudomonas aeruginosa ocular infection in rabbits.

Fraser-Smith EB, Matthews TR.

J Ocul Pharmacol. 1988 Summer;4(2):101-9.

PMID:
3262701
13.

Effect of ketorolac on herpes simplex virus type one ocular infection in rabbits.

Fraser-Smith EB, Matthews TR.

J Ocul Pharmacol. 1988 Winter;4(4):321-6.

PMID:
3246566
14.

The efficacy of an N-substituted imidazole, RS-49676, against a Trypanosoma cruzi infection in mice.

Scott VR, Matthews TR.

Am J Trop Med Hyg. 1987 Sep;37(2):308-13.

PMID:
3116868
15.

Effect of ketorolac on Candida albicans ocular infection in rabbits.

Fraser-Smith EB, Matthews TR.

Arch Ophthalmol. 1987 Feb;105(2):264-7.

PMID:
3492994
16.

In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)-guanine against cytomegaloviruses.

Duke AE, Smee DF, Chernow M, Boehme R, Matthews TR.

Antiviral Res. 1986 Aug;6(5):299-308.

PMID:
3021055
17.

Synthesis and anti-herpes-virus activity of acyclic 2'-deoxyguanosine analogues related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine.

Martin JC, McGee DP, Jeffrey GA, Hobbs DW, Smee DF, Matthews TR, Verheyden JP.

J Med Chem. 1986 Aug;29(8):1384-9.

PMID:
3016263
18.

Metabolism of ribavirin in respiratory syncytial virus-infected and uninfected cells.

Smee DF, Matthews TR.

Antimicrob Agents Chemother. 1986 Jul;30(1):117-21.

19.

Synthesis and antiherpes virus activity of phosphate and phosphonate derivatives of 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine.

Prisbe EJ, Martin JC, McGee DP, Barker MF, Smee DF, Duke AE, Matthews TR, Verheyden JP.

J Med Chem. 1986 May;29(5):671-5.

PMID:
3009811
20.

Antitrichomonal activity of mesoionic thiazolo[3,2-a]pyridines.

Walker KA, Sjogren EB, Matthews TR.

J Med Chem. 1985 Nov;28(11):1673-9.

PMID:
4067993
21.
22.

Synthesis and antiherpes simplex virus activity of 9-[(1,3-dihydroxy-2-propylthio)methyl]guanine.

McGee DP, Martin JC, Smee DF, Matthews TR, Verheyden JP.

J Med Chem. 1985 Sep;28(9):1242-5.

PMID:
2993615
23.

Activity of 9-(1,3-dihydroxy-2-propoxymethyl)guanine compared with that of acyclovir against human, monkey, and rodent cytomegaloviruses.

Freitas VR, Smee DF, Chernow M, Boehme R, Matthews TR.

Antimicrob Agents Chemother. 1985 Aug;28(2):240-5.

24.
25.
26.

Acyclic analogues of 2'-deoxynucleosides related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine as potential antiviral agents.

Martin JC, Jeffrey GA, McGee DP, Tippie MA, Smee DF, Matthews TR, Verheyden JP.

J Med Chem. 1985 Mar;28(3):358-62.

PMID:
3871860
28.
29.
31.

Lack of efficacy of AMP against recrudescent genital herpes infections in guinea pigs.

Fraser-Smith EB, Smee DF, Matthews TR.

Antimicrob Agents Chemother. 1983 Oct;24(4):611-2.

32.

Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

Smee DF, Martin JC, Verheyden JP, Matthews TR.

Antimicrob Agents Chemother. 1983 May;23(5):676-82.

33.

9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine: a new potent and selective antiherpes agent.

Martin JC, Dvorak CA, Smee DF, Matthews TR, Verheyden JP.

J Med Chem. 1983 May;26(5):759-61.

PMID:
6302255
34.
35.

Effect of salmon calcitonin on plasma calcium and phosphorus in pregnant and non-pregnant guinea pigs.

McKercher HG, Matthews TR, Derewlany LO, Radde IC.

Miner Electrolyte Metab. 1982 Dec;8(6):300-6.

PMID:
7167136
37.
38.

7-Ribosyl-3-deazaguanine--mechanism of antibacterial action.

Streeter DG, Miller M, Matthews TR, Robins RK, Miller JP.

Biochem Pharmacol. 1980 Jun 15;29(12):1791-7. No abstract available.

PMID:
6996683
39.

1-[4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl]-1H-imidazole nitrate, a new potent antifungal agent.

Walker KA, Braemer AC, Hitt S, Jones RE, Matthews TR.

J Med Chem. 1978 Aug;21(8):840-3.

PMID:
357722
40.

Microdilution transfer plate technique for determining in vitro synergy of antimicrobial agents.

Dougherty PF, Yotter DW, Matthews TR.

Antimicrob Agents Chemother. 1977 Feb;11(2):225-8.

41.

Synthesis and antifungal properties of certain 7-alkylaminopyrazolo[1,5-a]pyrimidines.

Novinson T, Robins RK, Matthews TR.

J Med Chem. 1977 Feb;20(2):296-9.

PMID:
319236
42.

Chemically defined medium for susceptibility testing of antimicrobial agents.

Dougherty PF, Yotter DL, Matthews TR.

Antimicrob Agents Chemother. 1976 Dec;10(6):923-5.

43.

Synthesis and antimicrobial evaluation of substituted 5,6-dihydro-5-nitrouracils.

Long RA, Matthews TR, Robins RK.

J Med Chem. 1976 Aug;19(8):1072-4.

PMID:
823335
44.

Synthesis and antiviral and antimicrobial activity of certain 1-beta-D-ribofuranosyl-4,5-disubstituted imidazoles.

Srivastava PC, Streeter DG, Matthews TR, Allen LB, Sidwell RW.

J Med Chem. 1976 Aug;19(8):1020-6.

PMID:
184281
45.

Imidazo(1,2-c)pyrimidine nucleosides. Synthesis and biological evaluation of certain 1-(beta-D-arabinofuranosyl)imidazo(1,2-c)pyrimidines.

Bartholomew DG, Huffman JH, Matthews TR, Robins RK, Revankar GR.

J Med Chem. 1976 Jun;19(6):814-6.

PMID:
781243
46.

Synthesis and antimicrobial activity of some novel heterocycles. Azolo-as-triazines.

Novinson T, Okabe T, Robins RK, Matthews TR.

J Med Chem. 1976 Apr;19(4):517-20.

PMID:
817024
47.

Synthesis and antimicrobial activity of certain imidazo[1,2-a]pyrimidines.

Revanker GR, Matthews TR, Robins RK.

J Med Chem. 1975 Dec;18(12):1253-5.

PMID:
811799
48.

Synthesis of 5-amino-1-(5-deoxy-beta-D-ribofuranosyl)imidazole-4-carboxamide and related 5'-deoxyimidazole ribonucleosides.

Srivastava PC, Newman AR, Matthews TR, Robins RK.

J Med Chem. 1975 Dec;18(12):1237-40.

PMID:
172632
49.

Differentiation in Coprinus lagopus. II. Histology and ultrastructural aspects of developing primordia.

Matthews TR, Niederpruem DJ.

Arch Mikrobiol. 1973;88(3):169-80. No abstract available.

PMID:
4119297
50.

Differentiation in Coprinus lagopus. I. Control of fruiting and cytology in initial events.

Matthews TR, Niederpruem DJ.

Arch Mikrobiol. 1972;87(3):257-68. No abstract available.

PMID:
4565491

Supplemental Content

Loading ...
Support Center